Here is the latest advance on Alzheimer’s disease

A brand new Fujirebio Diagnostics blood check identifies beta-amyloid, a mind plaque that may be a key marker for Alzheimer’s illness.

The Meals and Drug Administration cleared the check to switch PET scans and spinal fluid exams as the primary cease for symptomatic sufferers 55 and older.

Alzheimer’s sufferers even have two new remedies to gradual the development: Leqembi and Kisunla, IV infusions that assist clear the mind plaque.